SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

MRVI maintained at neutral by UBS

UBS maintained Maravai LifeSciences at neutral on MRVI.

MRVI

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.